Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, Keck PE Jr, Kirsch I, Krishnan KR, Kupfer DJ, Makuch RW, Miller FG, Pardes H, Post R, Reynolds MM, Roberts L, Rosenbaum JF, Rosenstein DL, Rubinow DR, Rush AJ, Ryan ND, Sachs GS, Schatzberg AF, Solomon S; Consensus Development Panel. Charney DS, et al. Among authors: kirsch i. Arch Gen Psychiatry. 2002 Mar;59(3):262-70. doi: 10.1001/archpsyc.59.3.262. Arch Gen Psychiatry. 2002. PMID: 11879164 Review.
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.
Rutherford BR, Wall MM, Brown PJ, Choo TH, Wager TD, Peterson BS, Chung S, Kirsch I, Roose SP. Rutherford BR, et al. Among authors: kirsch i. Am J Psychiatry. 2017 Feb 1;174(2):135-142. doi: 10.1176/appi.ajp.2016.16020225. Epub 2016 Sep 9. Am J Psychiatry. 2017. PMID: 27609242 Free PMC article. Clinical Trial.
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J. Locher C, et al. Among authors: kirsch i. JAMA Psychiatry. 2017 Oct 1;74(10):1011-1020. doi: 10.1001/jamapsychiatry.2017.2432. JAMA Psychiatry. 2017. PMID: 28854296 Free PMC article.
Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.
Evers AWM, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, Bingel U, Büchel C, Carvalho C, Colagiuri B, Crum AJ, Enck P, Gaab J, Geers AL, Howick J, Jensen KB, Kirsch I, Meissner K, Napadow V, Peerdeman KJ, Raz A, Rief W, Vase L, Wager TD, Wampold BE, Weimer K, Wiech K, Kaptchuk TJ, Klinger R, Kelley JM. Evers AWM, et al. Among authors: kirsch i. Psychother Psychosom. 2018;87(4):204-210. doi: 10.1159/000490354. Epub 2018 Jun 12. Psychother Psychosom. 2018. PMID: 29895014 Free PMC article.
What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus.
Evers AWM, Colloca L, Blease C, Gaab J, Jensen KB, Atlas LY, Beedie CJ, Benedetti F, Bingel U, Büchel C, Bussemaker J, Colagiuri B, Crum AJ, Finniss DG, Geers AL, Howick J, Klinger R, Meeuwis SH, Meissner K, Napadow V, Petrie KJ, Rief W, Smeets I, Wager TD, Wanigasekera V, Vase L, Kelley JM, Kirsch I; Consortium of Placebo Experts. Evers AWM, et al. Among authors: kirsch i. Psychother Psychosom. 2021;90(1):49-56. doi: 10.1159/000510738. Epub 2020 Oct 19. Psychother Psychosom. 2021. PMID: 33075796 Free article.
426 results